Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Menopause Transition, Sex Hormone Deficiency and Autonomic and Vascular Function

University of Minnesota · NCT06490146

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 45–55 · Women only
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
100
US sites recruiting
1
Study start
April 1, 2025
Record last updated
May 20, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This is a longitudinal study to determine the influence of the menopause transition on autonomic and vascular function. PI Keller-Ross has published data demonstrating that postmenopausal females have greater sympathetic neural reactivity during a stressor compared with age-matched males and younger females and males. A paucity of literature exists, however, on the role of the menopause transition in autonomic function because the majority of experimental studies on menopause physiology are cross-sectional and/or focused on older, postmenopausal females .

The influence of age on HTN is robust, whereas the effects of menopause are still unclear. Preliminary data demonstrate a clear association between age and sympathetic activity in females; how the transition through menopause influences these relations, however, remains unknown. The study will enroll 80 midlife (45-55 years of age) females to measure longitudinally the trajectory of autonomic and vascular function during the transition through menopause. The study hypothesizes that through the menopause transition, an increase in sympathetic activity and an impaired baroreflex sensitivity and endothelial function will emerge.

Being studied: No intervention

Conditions: Menopause

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Female
  • age 45-55 years
  • premenopausal
  • not using any medications determined to affect autonomic function
  • eumenorrheic
  • not planning to become pregnant for the duration of participation in the study
  • English-speaking, literate, willing and able to provide informed consent.

Exclusion Criteria

  • Diabetes
  • pregnant or breastfeeding
  • cardiac or pulmonary disorders
  • severe obesity (body mass index [BMI] ≥ 40 kg/m 2 )
  • hypertension
  • obstructive sleep apnea
  • current use of heart or blood pressure medications, current use of hormonal contraceptives or other forms of exogenous sex hormones
  • report of nicotine/tobacco use in the last six months, report of current alcohol abuse,
  • history of treatment with chemotherapy/radiation
  • coagulopathy disorders and/or use of anticoagulant medications, and current use of anxiolytics and/or antidepressants.

Recruiting US locations

  • University of Minnesota

    Minneapolis, MN 55414

    Site contact: Emma Lee · menopause@umn.edu

Study contacts (from the official record)

  • Emma Lee, PhD · 612-301-8617 · menopause@umn.edu
Menopause Transition, Sex Hormone Deficiency and Autonomic and… (NCT06490146) | Bored Studies